Immune checkpoint inhibitors or targeted therapy by mismatch repair status in endometrial cancer: a meta-analysis

Immune checkpoint inhibitors or targeted therapy by mismatch repair status in endometrial cancer: a meta-analysis

Objective This study evaluated the benefits of immune checkpoint inhibitors (ICIs) and/or targeted therapies in mismatch repair-deficient (dMMR) and mismatch repair-proficient (pMMR) patients with advanced or recurrent endometrial cancer (EC) via network meta-analysis.Methods English databases were...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yi Tang, Yan Chen, Ting Zeng, Kui Huang, Jing Zhao, Pu Zhang, Chuqiang Shu
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2025-12-01
Series:	Future Science OA
Subjects:	Endometrial cancer mismatch repair survival immune checkpoint inhibitors targeted therapies meta-analysis
Online Access:	https://www.tandfonline.com/doi/10.1080/20565623.2025.2541517
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The impact of mismatch repair (MMR), p53, and LCAM-1 immunohistochemical expression on prognosis in low-risk endometrial cancer
by: Şener Gezer, et al.
Published: (2025-06-01)

Microsatellite instability in endometrial cancer: the role of diagnostic methods and their clinical application. Expert consensus
by: A. S. Tyulyandina, et al.
Published: (2023-05-01)

The DNA mismatch repair protein, MSH6 is a novel regulator of PD-L1 expression
by: Kirsten Brooksbank, et al.
Published: (2025-09-01)

Study of Immunohistochemical Expression Patterns of Mismatch Repair Proteins in Endometrial Carcinoma and Endometrial Hyperplasia: An Institutional Study
by: Belani Vaishali Tulsidas, et al.

Early-stage endometrioid carcinoma with MSH6 protein deficiency: pitfalls in the diagnostic interpretation of microsatellite instability
by: Cheng Wang, et al.
Published: (2025-05-01)

Immunotherapy strategies and pharmaceutical care practice on a long-term surviving patient with advanced gastric cancer and mismatch repair deficient
by: Jinyin LI, et al.
Published: (2025-08-01)

Clinical Molecular Immunohistochemistry Mismatch Repair Mutations in Lynch Syndrome in Patients Under 50 Years: A Systematic Review
by: Bogdan Adrian Manta, et al.
Published: (2025-04-01)

Immune checkpoint inhibitor-related myocarditis during DUO-E regimen for endometrial cancer: The first case report in gynecologic oncology
by: Eri Yamabe, et al.
Published: (2025-10-01)

Measuring the effect of cell mismatch on PSPICE module model output
by: Zainab M. Kubba
Published: (2010-09-01)

Efficacy and safety of neoadjuvant toripalimab plus chemotherapy in localized deficient mismatch repair/microsatellite instability-high gastric or esophagogastric junction adenocarcinoma (NICE): a multicentre, single-arm, exploratory phase 2 studyResearch in context
by: Liying Zhao, et al.
Published: (2025-09-01)

Undifferentiated/Dedifferentiated Carcinomas of the Endometrium: A Retrospective Clinicopathological Study of a Series of 11 Cases
by: Reshmi J.S, et al.

Human papillomavirus and endometrial cancer (review of literature and meta-analysis)
by: M. К. Ibragimova, et al.
Published: (2021-03-01)

Clinicopathological features of colon cancer depending on the dMMR status of the tumor
by: S. S. Naumov, et al.
Published: (2024-01-01)

Cultural mismatch and accelerated epigenetic age during the transition to college
by: Yolanda Vasquez-Salgado, et al.
Published: (2025-07-01)

Concomitant anticoagulants and the survival of cancer patients treated with immune checkpoint inhibitors: a meta-analysis
by: Jin Xiong, et al.
Published: (2025-08-01)

Immune checkpoint blockades in gynecological cancers: A review of clinical trials
by: Hongling Peng, et al.
Published: (2022-09-01)

Human Epidermal Growth Factor Receptor 2 [HER‐2/neu] Amplification and Microsatellite Stable Status in Gastric and Gastroesophageal Adenocarcinoma: Assessing Frequency and Prognostic Implications at the Cancer Institute of Iran
by: Samaneh Salarvand, et al.
Published: (2025-08-01)

Characteristics and outcomes of primary and secondary resistance to immune checkpoint inhibitors in hepatocellular carcinoma
by: Xiaowen Cui, et al.
Published: (2025-06-01)

Application of Immune Checkpoint Inhibitors in Cancer
by: Zhijun Chen, et al.
Published: (2025-08-01)

Does adenomyosis influence tumor characteristics and survival in endometrioid-type endometrial cancer??
by: Gorkem Ulger, et al.
Published: (2025-05-01)

Microsatellite instability as a reliable marker of coexisting endometrial cancer in atypical endometrial hyperplasia
by: А. E. Protasova, et al.
Published: (2024-07-01)

Evaluating the Salary Mismatch Among Secondary School Teachears in Rubanda District.
by: Atukwase, Brian
Published: (2024)

MOLECULAR PROFILES OF ENDOMETRIAL HYPERPLASIA AND ENDOMETRIAL INTRAEPITHELIAL NEOPLASIA
by: S. A. Levakov, et al.
Published: (2018-08-01)

The impact of endometrial mechanical stimulation in women with normal hysteroscopic findings undergoing IVF/ICSI: a meta-analysis
by: Li-Jun Lin, et al.
Published: (2022-01-01)

ENDOMETRIAL PRECANCER: DEFINITION OF CONCEPTS, TACTICS
by: Iu. Iu. Tabakman, et al.
Published: (2016-09-01)

Dynamic SLAM algorithm adopt with eliminating mismatched point chains in grid motion statistics
by: Yong He, et al.
Published: (2025-07-01)

Relationship between abnormal p53 expression and high-risk histology in endometrial cancers and living in proximity to hog concentrated animal feeding operations in North Carolina
by: Jaye Boissiere, et al.
Published: (2025-08-01)

THE RESULTS OF COMPUTER MORPHOMETRY USED IN ENDOMETRIAL HYPERPLASIA
by: Yu. Yu. Tabakman, et al.
Published: (2016-06-01)

COPD patients with non-small cell lung cancer respond better to anti-PD-(L)1 immune checkpoint inhibitors
by: Augustin Boudoussier, et al.
Published: (2025-05-01)

Joint inference of mutational signatures from indels and single-nucleotide substitutions reveals prognostic impact of DNA repair deficiencies
by: Patricia Ferrer-Torres, et al.
Published: (2025-07-01)

Immune checkpoint inhibitor myocarditis: a systematic case study
by: E. A. Kushnareva, et al.
Published: (2020-12-01)

Prediction of prognosis of immune checkpoint inhibitors combined with anti-angiogenic agents for unresectable hepatocellular carcinoma by machine learning-based radiomics
by: Xuni Xu, et al.
Published: (2025-05-01)

Features of the course of pregnancy and childbirth after conservative treatment of initial atypical hyperplasia and endometrial cancer
by: A. V. Charkhifalakyan, et al.
Published: (2025-01-01)

Hyperplasia and endometrial precancer
by: O. A. Gornikh, et al.
Published: (2014-08-01)

Prosthesis-patient mismatch as a predictor of accelerated structural dysfunction of biological aortic valve prostheses
by: G. G. Khubulava, et al.
Published: (2022-09-01)

Imaging features and prognostic significance of immune checkpoint inhibitor–related pneumonitis in NSCLC
by: Xueqi Wang, et al.
Published: (2025-07-01)

Safety and efficacy of TACE combined with immune checkpoint inhibitors plus molecular targeted therapies in older adults with unresectable hepatocellular carcinoma
by: Xin Hong, et al.
Published: (2025-07-01)

The Impact of Immune Checkpoint Inhibitors on Fertility Preservation and Pregnancy Outcomes
by: Agata Prokopiuk, et al.
Published: (2025-05-01)

A Survey on the Deep Learning-Based Mismatch Removal: Principles and Methods
by: Shiyu Chen, et al.
Published: (2023-01-01)

Platelet-rich plasma combined withmesenchymal stem cells to repair endometrial injury
by: YE Ke, WEI Huafang, SONG Chengwen
Published: (2025-03-01)